2441 - 2450 of 7877 Results
Title
Year
-
OPENTitle: Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 1Start Page: 267End Page: 282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212851Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/248871/248871.pdfCitation Count: 34
-
RESTRICTEDTitle: Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1181End Page: 1188Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13347Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13347Citation Count: 19
-
OPENTitle: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease modelsJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.148649Best OA location URL: http://insight.jci.org/articles/view/148649/files/pdfCitation Count: 7
- Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption2021OPENTitle: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruptionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-26066-5Best OA location URL: https://www.nature.com/articles/s41467-021-26066-5.pdfCitation Count: 136
- Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease2021RESTRICTEDTitle: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's DiseaseJournal Name: Seminars in Thrombosis and HemostasisPublisher: Georg Thieme Verlag KGVol: 48Issue #: 03Start Page: 382End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0041-1733960Citation Count: 5
-
RESTRICTEDTitle: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulationJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6564Start Page: 201End Page: 206Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abi7852Citation Count: 104
-
RESTRICTEDTitle: Visual dysfunction is associated with cognitive impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005Citation Count: 8
-
OPENTitle: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0257372End Page: e0257372Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0257372Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0257372&type=printableCitation Count: 29
-
RESTRICTEDTitle: New Insights from a Two-Country Study Comparing Escalation Strategies for MS DrugsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80Citation Count: 0
-
RESTRICTEDTitle: Then and Now: 20 Years of Monumental Strides in Movement DisordersJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797984.85450.f1Citation Count: 0